I signed up for MyFreeDoctor yesterday morning and in the afternoon got a call from a nearby pharmacy that I had selected from their list. They are getting Ivermectin, but a supply now costs over $400, triple a year ago. The woman said that most patients are getting BOTH Ivermectin AND Hydroxychloroquine. Dr. George Fareed strongly recommends a combination of both.
A year ago, I decided to find an infusion center that would administer mAb treatments. It was almost impossible. In the past year, multiple web sites have come on line that now make it a lot easier to find them, but you still need to call to see if they have the medicine in stock.
Did you take your wife to the sixth infusion center? Did she get the treatment?
On January 24, the FDA amended the EUA for bamlanivimab and etesevimab (Eli Lilly, these are administered together) and REGEN-COV (Regeneron, combination of casirivimab and imdevimab), limiting their use to only when the patient has been exposed to or infected with a COVID variant known to be treatable with these drugs.
So you have to get a COVID diagnosis that does the genetic sequencing to determine what variant you have. Isn’t that a very high hurdle? I understand patients are not told which variant they have.
The NIH authorized Sotrovimab by GlaxoSmithKline for the Omicron variant. There are huge supply problems. Why in the world doesn’t GSK do an urgent license of their product to Eli Lilly and Regeneron and have them make it? The three of them could agree to cross-license products for future variants. There is huge demand right now and they all could make a lot of money via this business approach. Why doesn’t the Biden administration tell them to get together and cross-license?
A ten hour round trip for a 1% chance of getting them did not seem worth it. Additionally, the three drugs our local doctors prescribed were what gas_dr said would be helpful.
She got over what remained within nine additional days.
*** Why doesn’t the Biden administration tell them to get together and cross-license?***
Do you really think the government is here to help US citizens in any way? Especially this administration, which is the biggest disaster of my life, including the Carter administration.
FWIW, I believe that from the standpoint of clinical diagnosis, Delta tends to go for the Lower Respiratory Tract, Omicron the Upper. gas_dr posted about this a few days ago. However, current fatalities even with Omicron's dominance would suggest that as an absolute number, quite a few Omicron cases ARE still progressing to the lungs.
This leaves me with the question: Do the now limited monoclonals actually do harm if administered to a patient declining quickly, variant only suspected, and then it turns out he / she has Omicron?
The NIH authorized Sotrovimab by GlaxoSmithKline for the Omicron variant. There are huge supply problems. Why in the world doesn’t GSK do an urgent license of their product to Eli Lilly and Regeneron and have them make it? The three of them could agree to cross-license products for future variants. There is huge demand right now and they all could make a lot of money via this business approach.
Darn good point. I don't know. These companies have press conferences and interviews -- SOMEBODY should ask!
Why doesn’t the Biden administration tell them to get together and cross-license?
Well, the most likely explanation is incompetence. But, the Admin. has even more press conferences and interviews -- SOMEBODY should ask!!!